Healthcare -
Biotechnology - NYSE - DK
$ 85.25
-0.105 %
$ 372 B
Market Cap
28.8
P/E
NVO - SHORT-TERM DEBT
Short-term Debt NVO - Novo Nordisk A/S
6.48 B
LAST VALUE
-31.20%
2 YEAR CAGR
65.93%
5 YEAR CAGR
11.37%
10 YEAR CAGR